0001181431-12-044596.txt : 20120809 0001181431-12-044596.hdr.sgml : 20120809 20120809114642 ACCESSION NUMBER: 0001181431-12-044596 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120730 FILED AS OF DATE: 20120809 DATE AS OF CHANGE: 20120809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Koczynski Chester CENTRAL INDEX KEY: 0001555808 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14169 FILM NUMBER: 121019251 MAIL ADDRESS: STREET 1: ONE FRANKLIN PLAZA STREET 2: 200 NORTH 16TH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC CENTRAL INDEX KEY: 0000901219 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223178468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850-3338 BUSINESS PHONE: 3013098504 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 3 1 rrd352780.xml FORM 3 X0206 3 2012-07-30 1 0000901219 HUMAN GENOME SCIENCES INC HGSI 0001555808 Koczynski Chester ONE FRANKLIN PLAZA 200 NORTH 16TH ST PHILADELPHIA PA 19102 1 0 0 0 On July 30, 2012, the Reporting Person was appointed as a director of Human Genome Sciences, Inc. (the "Issuer") by GlaxoSmithKline plc ("GSK"), which at that time beneficially owned approximately 79%, or 158,660,878, of the outstanding shares of the Issuer (the "Shares") through its wholly owned subsidiary H. Acquisition Corp. ("HAC"). Pursuant to the Terms of the Agreement and Plan of Merger, dated as of July 16, 2012, by and among GSK, HAC and the Issuer, on August 2, 2012, HAC exercised its top-up option and, as the owner of more than 90% of the Shares, subsequently completed a short form merger with the Issuer. The Reporting Person disclaims any beneficial ownership (as defined in Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended) in the Shares. No securities are beneficially owned. /s/ Chester Koczynski, Director, Human Genome Sciences, Inc. 2012-08-09